5001352025-04-012025-09-305001352025-09-305001352025-03-315001352025-04-012025-09-30in-capmkt:OtherExpenses1Member5001352025-04-012025-09-30in-capmkt:ReportableSegments1Member5001352025-04-012025-09-30in-capmkt:ReportableSegments2Member5001352025-04-012025-09-30in-capmkt:ReportableSegments3Member5001352025-04-012025-09-30in-capmkt:ReportableSegments4Member5001352025-04-012025-09-30in-capmkt:ReportableSegments5Member5001352025-04-012025-09-30in-capmkt:ReportableSegments6Member5001352025-04-012025-09-30in-capmkt:ReportableSegments1Member5001352025-04-012025-09-30in-capmkt:ReportableSegments2Member5001352025-04-012025-09-30in-capmkt:ReportableSegments3Member5001352025-04-012025-09-30in-capmkt:ReportableSegments4Member5001352025-04-012025-09-30in-capmkt:ReportableSegments5Member5001352025-04-012025-09-30in-capmkt:ReportableSegments6Member5001352025-04-012025-09-30in-capmkt:ReportableSegments1Member5001352025-09-30in-capmkt:ReportableSegments1Member5001352025-04-012025-09-30in-capmkt:ReportableSegments2Member5001352025-09-30in-capmkt:ReportableSegments2Member5001352025-04-012025-09-30in-capmkt:ReportableSegments3Member5001352025-09-30in-capmkt:ReportableSegments3Member5001352025-04-012025-09-30in-capmkt:ReportableSegments4Member5001352025-09-30in-capmkt:ReportableSegments4Member5001352025-04-012025-09-30in-capmkt:ReportableSegments5Member5001352025-09-30in-capmkt:ReportableSegments5Member5001352025-04-012025-09-30in-capmkt:ReportableSegments6Member5001352025-09-30in-capmkt:ReportableSegments6Member5001352025-04-012025-09-30in-capmkt:ReportableSegments1Member5001352025-09-30in-capmkt:ReportableSegments1Member5001352025-04-012025-09-30in-capmkt:ReportableSegments2Member5001352025-09-30in-capmkt:ReportableSegments2Member5001352025-04-012025-09-30in-capmkt:ReportableSegments3Member5001352025-09-30in-capmkt:ReportableSegments3Member5001352025-04-012025-09-30in-capmkt:ReportableSegments4Member5001352025-09-30in-capmkt:ReportableSegments4Member5001352025-04-012025-09-30in-capmkt:ReportableSegments5Member5001352025-09-30in-capmkt:ReportableSegments5Member5001352025-04-012025-09-30in-capmkt:ReportableSegments6Member5001352025-09-30in-capmkt:ReportableSegments6Member5001352025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15001352025-04-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss1iso4217:INRxbrli:pureiso4217:INRxbrli:shares500135EPLNOTLISTEDINE255A01020EPL LIMITEDMain BoardEquity2025-04-012026-03-312025-11-112025-11-04INRMillionsHalf YearlyHalf yearlyGeographical2025-11-1110:55:002025-11-1112:25:00trueCash Flow IndirectNot applicable2025-04-012025-09-30UnauditedConsolidated231380000001990000002333700000097460000000-46300000045860000005660000001840000000448500000020760000000257700000002577000000604000000-9700000050700000002070000000000500000020750000001330000000340500000020430000003200000033680000003700000064000000026.396.37006.396.370.00260.01350.0556for note 4, please refer pdf filing. <BR> 5. EPL Limited (the 'Holding Company') and its subsidiaries are together referred to as 'the Group' in the following notes. The above consolidated unaudited financial results (the 'results') of the Group and its associate have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 "Interim Financial Reporting" ('Ind AS 34'), prescribed under section 133 of the Companies Act, 2013 and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 and Regulation 52(4) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 (as amended) read with SEBI Master Circular SEBI/HO/DDHS/DDHS-PoD-1/P/CIR/2025/0000000103 dated 11 July 2025. These results have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on 11 November 2025. The statutory auditors have carried out a limited review of the above results for the quarter and half year ended 30 September 2025. <BR> 6. Owing to restructuring of operations in Europe region, the Group had incurred a cost of Rs. 36 million during the year ended 31 March 2025, which was disclosed as an exceptional item. <BR> 7. During the quarter ended 30 September 2025, the Holding Company has allotted 2,60,320 equity shares of face value Rs. 2 each to option grantees upon exercise of options under the Holding Company's Employee Stock Option Scheme 2020. <BR> 8. The Board of Directors of the Holding Company, at its meeting held on 11 November 2025 have declared and approved interim dividend of Rs. 2.50 per equity share of Rs. 2 each fully paid up. The record date for the said purpose is fixed as 17 November 2025. <BR> 9. Amounts shown as '0' in the above results represent value less than Rupee one million.Other Expenses4485000000200480000008580000000115900000027600000049000000010300000046000000008400000013000000063400000012970000002455400000084020000008000000082290000002110000000850000003000000470000000109770000000663000000200420000000044596000000640000000255970000002623700000076000000263130000002678000000000130400000039820000002710000005820000000162000000499700000041480000009500000067430000006838000000120500000012191000000566000000266000000263000000013286000000001828300000044596000000AMESA7643000000EAP5633000000AMERICAS6442000000EUROPE5364000000Unallocated9000000Inter segmental elimination-19530000002313800000023138000000AMESA867000000EAP930000000AMERICAS776000000EUROPE435000000Unallocated-4000000Inter segmental elimination-600000002944000000566000000-2040000002582000000AMESA13986000000EAP9602000000AMERICAS11025000000EUROPE9115000000Unallocated2418000000Inter segmental elimination-155000000044596000000044596000000AMESA3914000000EAP3499000000AMERICAS2324000000EUROPE1976000000Unallocated7680000000Inter segmental elimination-111000000018283000000018283000000566000000-1198000000-1527000000000000106400000000018400000000-40000000002300000000280000002300000000-80000000-70000000088800000034650000000005000000000296500000000604800000058700000000000120000001681000000000000000000000000280000000-25000000-14880000000098000000000008580000000849800000019200000079800000054900000000-13590000001180000008300000020100000019090000002110000000Remeasurement gains/(losses) on defined benefit plan-3000000-3000000-1000000Exchange differences on translation of financial results of foreign operations1332000000133200000001330000000